Effect Of Nintedanib On Disease Progression In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis (ipf)

被引：0
|
作者：
Raghu, G. [1 ]
Inoue, Y. [2 ]
Behr, J. [3 ,4 ]
Cottin, V. [5 ]
Stowasser, S. [6 ]
Stansen, W. [6 ]
Maher, T. M. [7 ,8 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Clin Res Ctr, Osaka, Japan
[3] Klinikum Univ Munchen, Med Klin & Poliklin 5, Munich, Germany
[4] Asklepios Lungenfachkliniken Munchen Gauting, Munich, Germany
[5] Claude Bernard Univ Lyon 1, Louis Pradel Hosp, Lyon, France
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[7] Royal Brompton & Harefield NHS Fdn Trust, London, England
[8] Imperial Coll, Natl Heart & Lung Inst, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2693
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect Of Dose Reductions And/or Interruptions On The Efficacy Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Subgroup Analysis Of The Inpulsis Trials
    Maher, T. M.
    Inoue, Y.
    Case, A. H.
    Sakamoto, W.
    Stowasser, S.
    Wuyts, W. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [2] EFFECT OF DOSE REDUCTIONS AND/OR INTERRUPTIONS ON THE EFFICACY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): SUBGROUP ANALYSIS OF THE INPULSIS TRIALS
    Maher, T. M.
    Inoue, Y.
    Case, A. H.
    Sakamoto, W.
    Stowasser, S.
    Wuyts, W. A.
    THORAX, 2017, 72 : A253 - +
  • [3] Nintedanib Reduces Disease Progression in Patients With Idiopathic Pulmonary Fibrosis Irrespective of GAP Stage at Baseline in the INPULSIS Trials
    Belperio, John
    Ryerson, Christopher
    Kolb, Martin
    Richeldi, Luca
    Lee, Joyce
    Stansen, Wibke
    Stowasser, Susanne
    Poletti, Venerino
    CHEST, 2016, 150 (04) : 540A - 540A
  • [4] Efficacy and Safety of Nintedanib in US and Non-US Patients With Idiopathic Pulmonary Fibrosis (IPF) in the INPULSIS Trials
    Huggins, John
    Kaye, Mitchell
    Bailes, Zelie
    Esser, Dirk
    Conoscenti, Craig
    Flaherty, Kevin
    CHEST, 2015, 148 (04)
  • [5] Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
    Collard, Harold R.
    Richeldi, Luca
    Kim, Dong Soon
    Taniguchi, Hiroyuki
    Tschoepe, Inga
    Luisetti, Maurizio
    Roman, Jesse
    Tino, Gregory
    Schlenker-Herceg, Rozsa
    Hallmann, Christoph
    du Bois, Roland M.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [6] Nintedanib Reduces Disease Progression in Patients With Idiopathic Pulmonary Fibrosis Irrespective of Composite Physiologic Index at Baseline in the INPULSIS Trials
    Wells, Athol
    Behr, Juergen
    Stansen, Wibke
    Stowasser, Susanne
    Maher, Toby
    CHEST, 2016, 150 (04) : 539A - 539A
  • [7] POOLED ANALYSIS OF MORTALITY DATA FROM THE TOMORROW AND INPULSIS TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Corte, T.
    Richeldi, L.
    Kirsten, A.
    Roman, J.
    Le Maulf, F.
    Hallmann, C.
    Stowasser, S.
    Lasky, J.
    RESPIROLOGY, 2015, 20 : 87 - 87
  • [8] Subgroup analysis of Asian patients in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis
    Taniguchi, Hiroyuki
    Xu, Zuojun
    Azuma, Arata
    Inoue, Yoshikazu
    Li, Huiping
    Fujimoto, Tsuyoshi
    Bailes, Zelie
    Schlenker-Herceg, Rozsa
    Kim, Dong S.
    RESPIROLOGY, 2016, 21 (08) : 1425 - 1430
  • [9] Improvement In Forced Vital Capacity (FVC) With Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From The Inpulsis Trials
    Flaherty, K. R.
    Kolb, M.
    Vancheri, C.
    Tang, W.
    Conoscenti, C. S.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE INPULSIS™ TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS
    Taniguchi, H.
    Xu, Z.
    Azuma, A.
    Inoue, Y.
    Li, H.
    Fujimoto, T.
    Bailes, Z.
    Schlenker-Herceg, R.
    Kim, D. S.
    RESPIROLOGY, 2014, 19 : 30 - 30
12345